BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Naloxone

A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.

299+ PubMed studies analyzed · 5 RCTs · Evidence Score: 47.7

Research Domains

Naloxone has been studied across 14 research domains including 💊 Pain, 😴 Sleep, ❤️ Cardiovascular, 🫁 Respiratory, 🫁 Liver & Detox. The primary research focus is 💊 Pain with 65% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Naloxone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nalbuphine
8 shared targets
Butorphanol
7 shared targets
hydrocodone
6 shared targets
Morphine
8 shared targets
Oxycodone
6 shared targets
Hydromorphone
5 shared targets
Meperidine
5 shared targets
Levallorphan
6 shared targets
Etorphine
4 shared targets
beta-Endorphin
4 shared targets
Loading evidence profile...

This evidence profile for Naloxone is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.